SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-193262
Filing Date
2019-07-12
Accepted
2019-07-12 16:47:02
Documents
1
Group Members
QVT ASSOCIATES GP LLCQVT FAMILY OFFICE FUND LPQVT FINANCIAL GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D d765600dsc13da.htm SC 13D/A 73737
  Complete submission text file 0001193125-19-193262.txt   75511
Mailing Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 19953376
SIC: 2834 Pharmaceutical Preparations